Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis

Many studies have indicated that Gankyrin is a promising and novel prognostic tumor biomarker. However, the results of different studies remained controversial. Hence, a meta-analysis was undertaken to investigate the association between Gankyrin expression and cancer prognosis. Eligible studies wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaotong, Liu, Fangzhou, Zhang, Yuan, Li, Peihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831594/
https://www.ncbi.nlm.nih.gov/pubmed/27110125
http://dx.doi.org/10.2147/OTT.S101687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831594/
https://www.ncbi.nlm.nih.gov/pubmed/27110125
http://dx.doi.org/10.2147/OTT.S101687

Ejemplares similares